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Abstract
The set-up of an on-line method for coupling nonaqueous electrokinetic chromatography (NAEKC) and electrospray ionization mass spectrometry (ESI-MS) is presented. It allows the use of the single-isomer derivative anionic cyclodextrins heptakis(2,3-di-O-methyl-6-O-sulfo)-β-cyclodextrin (HDMS-β-CD) and heptakis(2,3-di-O-acetyl-6-O-sulfo)-β-cyclodextrin (HDAS-β-CD) for chiral and achiral separations of positively charged analytes. The effect of the cyclodextrins (CDs) on the MS signal intensities of model compounds was studied. When a voltage is applied over the CE capillary, the overall mobility of the CDs is towards the inlet vial preventing CDs from entering the ion source. However, the sodium counter ions of the CDs still enter the ion source and appeared to cause ionization suppression. Nevertheless, significant analyte signals could still be detected with detection limits in the sub-µg/ml. System parameters such as sheath liquid composition and flow rate, nebulizing gas pressure, capillary position in the sprayer and the drying gas flow and temperature were studied and optimized. The selection of a relatively low nebulizing gas pressure appeared to be important to achieve optimum sensitivity. The chiral selectivity of the NAEKC-ESI-MS system could be improved by addition of camphorsulfonate to the background electrolyte. Using mixtures of drugs and drug-related compounds, the NAEKC-ESI-MS system is shown to offer potential for (chiral) drug profiling.
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1. Introduction
During the last decade nonaqueous capillary electrophoresis (NACE) has gained strong interest [1,2]. Compared to aqueous CE, NACE offers different and/or improved selectivity, enhanced solubility for compounds of low polarity, and relatively low conductivity of the background electrolyte (BGE). Recently, the power of NACE systems implementing anionic modified sulfated cyclodextrins - more properly denoted as nonaqueous electrokinetic chromatography (NAEKC) - has been demonstrated [3-5]. In particular for chiral analysis, NAEKC has demonstrated to be an excellent method because of its high selectivity, ease of method development, and low consumption of (often expensive) pseudo-stationary phases (PSPs) [1-5].
The combination of NACE and electrospray ionization mass spectrometry (ESI-MS) is highly useful in order to achieve lower detection limits than with UV detection, and to accomplish the identification of separated compounds. In comparison to aqueous CE-MS systems, enhanced sensitivities and better system stabilities have often been obtained using NACE-ESI-MS [6-8]. However, the nonvolatile cyclodextrins (CDs) as used in NAEKC could hamper the coupling with ESI-MS. For coupling aqueous CD-EKC with MS different approaches have been described. The direct approach, in which CDs are allowed to enter the ion source, indeed shows severe interferences with analyte ionization and detection [9-11]. In order to prevent CDs from entering the ion source, partial-filling techniques have been used in which only a (small) part of the CE capillary is filled with BGE containing the CDs [12-14]. This technique improves compatibility with MS, however, separation may be compromised. Another approach is the use of so-called reverse-migrating CDs in which the CDs have an overall mobility towards the inlet vial and, thus, do not enter the ion source [15-17]. Using this approach, the capillary in principle can be filled completely with CD-containing BGE at the start of the analysis, which is advantageous in terms of separation efficiency and resolution.
Recently, we showed the feasibility of reverse-migrating CDs in NAEKC-MS [18]. The anionic CD heptakis(2,3-di-O-acetyl-6-O-sulfo)-β-cyclodextrin (HDAS-β-CD) was used for the chiral analysis of salbutamol in urine using sensitive MS detection.
In this paper, a more in-depth study of the set-up and performance of the previously presented system is reported. The effect of parameters such as the composition of the BGE, the type and concentration of CD, the counter-ion of the anionic CD, and CE voltage was studied by infusion experiments. Furthermore, the effect of the sheath liquid flow rate, the nebulizing gas pressure, and the interface settings on the ionization performance was investigated. It is demonstrated that the developed CD-NAEKC-ESI-MS system shows good sensitivity and has potential for the chiral and achiral analysis of drugs.
2. Experimental
2.1. Chemicals and materials
Sodium formate, ammonium formate, potassium formate, and acetic acid (99-100%) were purchased from Merck (Darmstadt, Germany). Pyridoxine, imipramine, deptropine, atropine, chlorpromazine, hydroxypropyl-β-cyclodextrin (HP-β-CD), (1S)-(+)-10-camphorsulfonic acid, and formic acid (98-100%) were purchased from Sigma -Aldrich (Zwijndrecht, The Netherlands). Fluvoxamine, mebeverine (veratric acid 4-[ethyl(p-methoxy-α-methyl-phenethyl)amino]-butyl ester hydrochloride), mebeverine amine (N-ethyl-4-methoxy-α-methylbenzeneethamine), butoverine (4-dimethoxybenzoic acid, 4-{ethyl[2-(4-methoxyphenyl)-l-methylethyl]amino} butyl-4-oxo-butylester), mebeverine alcohol (4-[ethyl[2-(4-methoxyphenyl)-1 -methylethyl] amino] -1 -butanol), mebeverine quartenary ammonium iodide compound (l-ethyl-l-[l-methyl-2-(4-methoxyphenyl)ethyl]-pyrrolidinum, iodide), and desmethyl mebeverine (3-hydroxy-4-methoxybenzoic acid, 4-[ethyl[[l-methyl-2-(4-methoxyphenyl)ethyl]amino]butyl ester) were kindly provided by Solvay Pharmaceuticals (Weesp, The Netherlands). All reagents were of analytical grade. The sodium salts of heptakis(2,3-di-O-acetyl-6-O-sulfo)-β-cyclodextrin (HDAS-β-CD) and heptakis(2,3-di-O-methyl-6-O-sulfo)-β-cyclodextrin (HDMS-β-CD) were obtained from Antek Instruments (Houston, TX, USA). Deionized water was filtered and degassed before use. Methanol and acetonitrile (both HPLC grade) were from Biosolve (Valkenswaard, The Netherlands). Fused-silica capillaries were from Polymicro Technologies (Phoenix, AZ, USA).
For the infusion experiments, 1-µg/ml mebeverine or salbutamol solutions were prepared in l0mM ammonium formate, 0.75M formic acid in methanol containing 0-30mM of sodium formate, potassium formate, HP-β-CD, HDMS-β-CD or HDAS-β-CD. The test mixture of basic drugs was prepared in methanol at a concentration of 10 µg/ml of each compound. The test mixture containing mebeverine and its related compounds was prepared in methanol at a concentration of 20 µg/ml of each compound. The composition of the sheath liquid was acetonitrile-water-formic acid (75:25:0.1, v/v/v).
2.2. CE-MS system
NAEKC-ESI-MS experiments were performed using a PrinCE CE system (Prince Technologies, Emmen, The Netherlands) equipped with an Agilent 1100 Series LC/MSD SL ion-trap mass spectrometer from Agilent Technologies. A fused-silica separation capillary of 50 cm length, and an internal diameter of 50 µm, was used. A new capillary was conditioned with methanol for 15 min. At the beginning of each working day, the capillary was washed with methanol for 10 min and with the BGE for 10 min. Before each injection, the capillary was rinsed with fresh BGE for 3 min. The applied voltage was 30 kV. Samples were injected by applying a pressure of 50 mbar for 6 s. During infusion experiments, BGE containing the test compound was pumped into the ion source through the CE capillary by applying a constant pressure of 50 mbar. Alternatively, a voltage of 30 kV was applied to mimic the conditions during CE-MS analysis. Subsequently, the analyte signals were monitored in their respective extracted-ion-trace (XIC).
NAEKC was coupled to MS using a coaxial CE-MS sprayer (Agilent Technologies, Waldbronn, Germany) which provides both a coaxial sheath liquid make-up flow and a nebulization gas to assist droplet formation. Using optimized conditions, the flow-rate of the sheath liquid was 4 µl/min, the nebulizing gas pressure was 2p.s.i., the drying gas flow rate was 11/min at a temperature of 150 °C. Drying and nebulization gases were nitrogen. During rinsing of the CE capillary with the BGE and during CE injection, the nebulizer gas flow and the electrospray voltage (+5.0 kV) were switched off. MS detection was carried out in the full scan mode in the 50-700 m/z mass range, unless stated differently. The ion-charge-control (ICC) mode of the MS was used to prevent overloading of the trap. The plate numbers and asymmetry factors were calculated according the European Pharmacopoeia [19].
3. Results and discussion
3.1. Effect of CD on MS performance
The presence of cyclodextrins in the BGE may affect the analyte ionization efficiency in CE-MS [10]. In the present study, the effect of a neutral and an anionic CD on the ionization yield of a model compound (mebeverine) was studied by infusion of the BGE containing the model compound into the ESI ion source using either a pressure or a voltage induced flow. The neutral hydroxypropyl-β-cyclodextrin (HP-β-CD) and the anionic heptakis(2,3-di-O-methyl-6-O-sulfo)-β-cyclodextrin (HDMS-β-CD) were added in various concentrations (0-30 mM) to a BGE of 10 mM ammonium formate and 0.75 M formic acid in methanol. When a solution of the neutral CD was infused by pressure, a strong decrease of the signal of mebeverine was observed, even at relatively low CD concentrations (Fig. 1A, upper trace). With an increasing concentration of CD, the mebeverine signal gradually decreased to almost zero at 30 mM of CD. The CD clearly strongly interferes with the ionization of mebeverine.
During NAEKC-MS experiments, the actual ionization conditions are different from pressure-induced infusion due to the electro-osmotic flow (EOF) and the electrophoretic mobilities of analyte and CD (if charged). Therefore, infusion experiments were also performed while applying a voltage across the CE capillary, but no pressure. The EOF was relatively small (EOF time of ca. 13 min) and appeared to be hardly affected by the type and concentration of CD. When using the BGE containing the neutral CD, the EOF will cause the neutral CD to enter the ion source. Indeed, a strong decrease of the analyte signals is also observed when a voltage is applied (Fig. 1 A, lower trace). The mass spectra when using the neutral HP-β-CD with either pressure- or voltage-induced infusion, are dominated by a large number of signals, which are related to the CD (Fig. 2A). Interpretation of the mass spectra is not easy because of the heterogeneity of the CD. Also mass shifts and broadening of the spectral peaks of mebeverine were observed.

Fig. 1. Influence of the (A) HP-β-CD and (B) HDMS-β-CD concentration on the relative MS signal of 1 µg/ml mebeverine (monitored at m/z 430) dissolved in 10 mM ammonium formate and 0.75 M formic acid. Upper traces represent the signals observed during infusion by applying a pressure of +50 mbar, and lower traces represent the signals observed when a voltage of 30 kV and no pressure was applied.


Fig. 2. Background mass spectra obtained during NAEKC-ESI-MS analysis using a BGE of 10 mM ammonium formate and 0.75 M formic acid with (A) 10mM HP-β-CD or (B) 10mM HDMS-β-CD. The signals at mlz 279 and mlz 391 are not caused by the BGE but originate from dibutyl phthalate and dioctyl phthalate, respectively.

When a BGE containing the anionic HDMS-β-CD is introduced using a pressure-induced flow, also astrong suppression of the analyte ionization is observed (Fig. 1B, upper trace) and the mass spectra are noisy showing a large number of background signals, including sodium clusters. The mebeverine signal using the anionic CD is even more reduced compared to using the neutral CD, which could be due to the fact that ionization suppression is caused by both the CD and its sodium counter ions. However, using HDMS-β-CD the loss of analyte signal intensity is much less severe when a voltage is applied (Fig. 1B, lower trace), also when compared to the neutral CD. With the CE voltage on, the EOF being small, the negatively charged CDs have an overall mobility towards the capillary inlet, and, thus, will not enter the ion source. This is confirmed by the fact that when a voltage is applied, the background spectrum shows only some discrete signals, which appear to originate from sodium formate clusters (Fig. 2B). No signals or extra noise caused by the anionic CDs were observed in the range up to 2200 m/z. The sodium formate clusters originate from the sodium counter ions of the anionic CDs - having an overall mobility towards the capillary outlet - which form clusters with the formate ions present in the sheath liquid. In order to verify that the overall mobility of the anionic CDs is towards the anodic end, the MS settings were adapted for optimum transfer and detection of the CDs instead of low-molecular-weight basic drugs, and the same experiments were carried out. Again, clear CD-related signals showed up when a pressure was applied, however, these signals completely disappeared when only a voltage was applied. This observation confirms that no anionic CDs enter the ion source during NAEKC-MS.
In order to study the magnitude of ionization suppression caused by the sodium ions, voltage-induced infusion experiments were performed with mebeverine solutions containing different concentrations of sodium formate. When the observed mebeverine signals were plotted as a function of sodium formate concentrations, the resulting curve showed a high similarity with the one obtained for the anionic CD as shown in Fig. 1B (lower trace). In other words, equimolar amounts of HDMS-β-CD and sodium formate cause approximately the same degree of ionization suppression, if we assume that no CD molecules enter the ion source. Therefore, the concentration of free sodium ions is nearly the same, which confirms that the global dissociation of the sodium salt of the anionic CD is very low in our nonaqueous BGE. We are currently studying the dissociation behaviour of anionic CDs in methanolic media in more detail.
3.2. Optimization of interface parameters
The former infusion experiments showed that despite ionization suppression, significant analyte signals can be obtained under NAEKC-MS conditions with anionic CDs. For further optimization of the NAEKC-MS system, parameters like sheath liquid flow rate, nebulizing gas pressure, capillary sprayer position and drying gas flow and temperature, were studied. In order to mimic the conditions during NAEKC-MS analyses, this was done by voltage-induced infusion of the test compound mebev-erine in the BGE. A BGE of 10 mM ammonium formate, 0.75 M formic acid in methanol containing 10 mM HDAS-β-CD, was used.
In previous studies using both aqueous and nonaqueous CE-MS, the sheath liquid composition was optimized [18,20]. The optimum composition for basic drugs was found to be acetonitrile-water-formic acid (75:25:0.1, v/v/v) [18,20], and therefore this composition was also used in this study. The flow rate of the sheath liquid was varied between 1 and 10 µl/min. The spray and mebeverine signal were stable for a flow down to 3 µl/min. An increase of the flow resulted in a slight decrease of signal intensities (Fig. 3A). This observation seems to be in contrast with CE-MS using a volatile BGE where a relatively stronger decrease in analyte signals is observed with increasing sheath liquid flow rates [21]. This apparent deviating trend is most probably caused by a distortion of the analyte ion evaporation process by the sodium ions of the CDs. The increase of the sheath liquid flow causes an increased dilution of the analyte concentrations entering the ion source. When a fully volatile BGE is used, this normally leads to reduction of signal, as ESI can be considered a concentration-dependent process [22]. However, when sodium ions are present in the CE effluent, the surface of the electrospray droplets is saturated with sodium ions and analyte ion evaporation is disturbed yielding suppressed analyte signals. The concentration of sodium ions is relatively high and the analyte-sodium ratio remains constant when the sheath liquid flow rate is varied. Under such conditions the signal is predominantly determined by the suppression of the sodium ions and less by the sheath liquid dilution. The effect of sodium ions could be verified by the infusion of 1 µg/ml mebeverine in BGE containing sodium formate (1, 5 and 10 mM) instead of HDAS-β-CD. For 10 mM sodium formate, the sheath liquid flow rate only had a modest effect on the mebeverine signal showing little decrease with increasing flow rate. With 1 mM sodium formate, the mebeverine signal obtained at low sheath liquid flow rate was considerably higher (less ionization suppression), however, the signal showed a much steeper decline when the sheath liquid flow rate was increased. A sheath liquid flow rate of 4 µl/min was selected in further experiments.
When using a BGE with HDMS-β-CD, we found that the nebulization gas pressure has a signal-reducing effect in the 2-8 p.s.i. range (Fig. 3B). This effect levels out at between 10 and 15 p.s.i, and when the pressure is further increased to 20 p.s.i, the signal even increases. This dependency was also observed when no CDs were used in the BGE. Apparently, a small flow of nebulization gas is sufficient because of the high percentage of organic solvent in the sheath liquid and BGE. The nebulizer gas then just diffuses the gas stream, reducing the analyte ion sampling efficiency. The increasing signal above l0 p.s.i. (Fig. 3B) is caused by the fact that high nebulization gas flows induce a hydrodynamic flow in the CE capillary. As a consequence, the amount of analyte that enters the ion source per unit time increases resulting in increased analyte signals. In order to achieve optimum signals and to prevent hydrodynamic flow and, thus, loss of CE separation efficiency, a nebulizing gas pressure of 2p.s.i. was used in further experiments.
The position of the CE capillary in the CE-MS sprayer is of importance for the efficiency of the mixing of the CE capillary effluent and the sheath liquid, and the subsequent nebulization. The position was varied between -0.1 and +0.2 mm out of the sheath liquid capillary (i.e. -1 to +2 marks on the sprayer, respectively). Over the entire range stable signals could be obtained, however, a position of +0.1 mm was found to give the highest signals under NAEKC conditions. Finally, the drying gas flow rate (1-101/min) and temperature (100-300 °C) were tested. Our experiments (data not shown) indicated that for organic BGEs containing nonvolatile additives, a low drying gas flow rate of 1 l/min was sufficient in combination with a temperature of 150 °C. Drying gas flow rates above 6 l/min resulted in a minor decrease of MS signals. Furthermore, no significant change in analyte signals were observed when the temperature was varied in the range mentioned. High drying gas flow rates combined with high temperatures are not required in (nonaqueous) CE due to the relative low solvent flow rate and the high volatility of the solvents used. These results are in line with results reported by other authors concluding that variation of these parameters only had a minor effect on the observed signal intensities [1,22].
3.3. CD-NAEKC-ESI-MS
The experiments described above indicate that significant analyte signals can be recorded using anionic CDs in NAEKC-ESI-MS. The feasibility of this methodology was further tested by analysis of a test mixture containing six basic drugs: pyridoxine, chlorpromazine, imipramine, fluvoxamine, deptropine, and atropine (l0µg/ml each). A BGE of 10mM ammonium formate, 0.75 M formic acid in methanol was used [18], containing no CDs, 5 mM HDMS-β-CD or 5 mM HDAS-β-CD. Using these systems, all compounds were detected as their respective protonated-molecular ion in the corresponding XICs (Fig. 4A-C). Stable signals were obtained, and the noise levels were similar for the systems with and without CDs. The intensity of the observed peaks using a BGE with 5 mM anionic CDs is approximately 25% of the intensity obtained without CDs due to ionization suppression by sodium ions. In full-scan mode (scan range, 50-700 mlz) LODs between 0.25 and 1.0 µg/ml were obtained when 5 mM of anionic CDs was used in the BGE, which is approximately four times higher than the LODs obtained using the BGE without CDs. By reducing the scan range or by using single-ion-monitoring, LODs in the low ng/ml-range could be obtained in the presence of CDs [18]. With UV absorbance detection, the LODs of the analytes were all above 1 µg/ml indicating that MS detection provides both enhanced selectivity and sensitivity.
Looking at separation performance, the resolution obtained for the mixture components using the BGE without CD, was quite poor. Furthermore, the plate numbers (N) were mediocre (N ≤ 20.000) and the peaks were tailing with asymmetry factors between 2 and 3. Addition of 5mM HDMS-β-CD to the BGE (Fig. 4B), increased the selectivity and migration times due to the interaction with the CD, but no full separation was obtained. Partial chiral separation was observed for atropine (mlz 290) and fluvoxamine (mlz 319). Addition of 5 mM of HDAS-β-CD to the BGE (Fig. 4C) provided quite a different selectivity. All mixture compounds were now separated, however, no chiral resolution was observed. With the NAEKC-MS systems, plate numbers and peak shapes were satisfactory with plate numbers up to 100.000 and asymmetry factors ranging between 0.9 and 1.8.







Fig. 4. NACE/NAEKC-MS of a test mixture of basic drugs (10 µg/ml each) containing pyridoxine (m/z 170), imipramine (m/z 281), atropine (m/z 290), chlorpromazine and fluvoxamine (both m/z 319), and deptropine (m/z 334). BGE, 10 mM ammonium formate and 0.75 M formic acid, containing (A) no anionic CD, (B) 5 mM HDMS-β-CD and (C) 5 mM HDAS-β-CD. Extracted-ion-chromatograms are depicted.






To enhance the enantiomer separation of basic pharmaceuticals in NACE, Crommen and coworkers have demonstrated the usefulness of the ion-pairing reagent (1S)-(+)-10-camphorsulfonate (CS) in combination with anionic CDs [23,24]. The simultaneous use of CS and an anionic β-CD derivative in a methanolic BGE, led to enantioresolutions, which often could not be obtained with the CD only. In order to check the compatibility of such NAEKC systems with ESI-MS, a test mixture of mebeverine and structure analogues was analyzed using a separation system containing 30 mM HDMS-β-CD, 30 mM potassium CS and 0.75 M formic acid in methanol as previously used by Servais et al. [23]. Using the NAEKC-ESI-MS system, the enantiomers of mebeverine and all related compounds could be separated and detected within one single analysis (Fig. 5). Compared to the analyses without HDMS-β-CD and/or CS, significant improvements in both achiral and chiral selectivity was obtained. No signals related to the CS or CD were observed in the recorded mass spectra which confirms that both selectors migrate towards the capillary inlet. The peak shapes of the mebeverine enantiomers (mlz 430) are somewhat distorted due to interference with a background signal at mlz 431 caused by a sodium formate cluster. Such interferences by sodium clusters can easily be avoided by using e.g. acetic acid in the sheath liquid instead of formic acid. This will result in sodium acetate clusters, which are detected at other m/z-values. The background spectra observed using NAEKC-ESI-MS using anionic CDs and CS showed sodium and potassium formate clusters which originate from the respective counter ions of the CD and CS. Infusion experiments with potassium formate demonstrated that analyte suppression by potassium ions was similar to suppression by sodium ions (data not shown). Still, the remaining analyte signals were quite satisfactory. Using NAEKC-ESI-MS with anionic CDs and CS, LODs were in the sub-µg/ml-range.
4. Conclusions
The coupling of NAEKC using anionic CDs to ESI-MS was studied and accomplished. CDs in principle may suppress analyte ionization, however, as the effective mobility of the used anionic CDs is towards the capillary inlet, signal reduction by the CDs could be circumvented. Nevertheless, the sodium counter ions of the anionic CDs migrate into the ion source causing ionization suppression, but stable and significant analyte signals were still obtained. The potential of CD-NAEKC-ESI-MS for improving chiral and achiral selectiv-ities was demonstrated using some test drugs. In full-scan mode (50-700 mlz), LODs in the sub-µg/ml range were obtained, which can be considered to be sufficient for use of this technique in drug impurity profiling of drugs. Considering the adverse effect of the CD counter ions on the ESI-MS performance, it would be favourable to have anionic CDs available with volatile counter ions like, e.g., ammonium ions. With such CDs, ionization suppression by the counter ion would be fully prevented. Moreover, the formation of ion clusters, which may interfere with analyte signals, would be circumvented. Prerequisite for the effectiveness of such ammonium CDs would be that they show sufficient dissociation in a nonaqueous environment.
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